Please login to the form below
digital biomarkers
This page shows the latest digital biomarkers news and features for those working in and with pharma, biotech and healthcare.
Voice biomarker device could diagnose depression, heart disease
Sonde Health raises $16m in series A round. Technology that detects ‘vocal biomarkers’ from just a few seconds of speech could soon help speed up diagnosis of conditions such as depression ... The technology then measures subtle changes in pitch,
Latest news
-
Digital Trials
In order to generate insights and digital biomarkers, data scientists who are skilled experts in advanced analytics are needed. ... sets. Artificial Intelligence and machine learning can generate new insights and digital biomarkers that have.
-
Takeda explores the potential of ‘digital biomarkers’
Collaborates with Mindstrong Health on mental health research. Takeda is exploring the potential of ‘digital biomarkers’ to help develop new mental health treatments, with a particular focus on schizophrenia and ... The companies hope that by joining
Digital Trials
Takeda explores the potential of ‘digital biomarkers’
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
2. Digital medicine (eg, digital diagnostics and biomarkers, where requirements for regulatory oversight vary). ... Currently, very few initiatives and guidance for formally evaluating digital health are available.
-
Integrating digital biomarkers into precision medicine
How can we use digital biomarkers? Digital biomarkers can be integrated into an existing biomarker strategy as a complementary tool or as a stand-alone measure. ... Regulators and payers are also increasingly interested in the insights yielded by digital
-
Managing medication non-adherence
In the near term, digital biomarkers have great potential to enrich clinical trials. ... Provide opportunities for engagement. Solutions don’t have to revolve around data capture and validating digital biomarkers.
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Integrating digital biomarkers into precision medicine
Managing medication non-adherence
More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Artificial Intelligence for Identifying and Monitoring Cognitive Decline
Liam Kaufman, CEO &Co-founder of Winterlight Labs, joins Natalie Yeadon, Co-owner &Managing Director at Impetus Digital, for this live Fireside Chat. ... Today, we are exploring a range of topics related to AI, machine learning, natural language
More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Events Executive
-
Depending on Experience
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Digital Project Director, Healthcare Marketing Agency patient fo...
-
Highly competitive salary
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
-
Digital account director
-
Competitive
- Project Director, Healthcare Marketing Agency patient focus Lond...
-
Highly competitive salary
- Senior Consultant, Pricing & Market Access Consultancy, circ...
-
circa £100K package
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- CHMP rejects Kyowa Kirin’s Parkinson’s disease drug
- Google’s DeepMind opens ‘breakthrough’ protein database to the world
- Distracted boyfriend: the secret of a successful long-distance relationship
- Merck & Co’s sales bounce back in ‘ongoing recovery from COVID-19’
- Lilly and Kumquat Biosciences link up in $2bn-plus immuno-oncology deal
- Michael J. Fox Foundation and IBM reveal new AI model for Parkinson’s disease
- BMS’ Q2 results beat expectations with strong performance across core therapy areas
- Amanda Pritchard becomes NHS England’s first female chief executive
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- Vertex gains FDA fast track designation for diabetes stem cell therapy
- Onyx Health Launch Creative Studio After Record Year
- Roche appoints Philip Atkinson to new global role
- AZ’s comeback drug cediranib stumbles in phase 3 trial
- MHRA outlines two-year delivery plan with ‘patient first’ focus
PMHub
Six Degrees Medical Consulting
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...
Latest intelligence
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
- Employee wellbeing in creative agencies: three tips to get you started
- Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
- Managing unhelpful pressure in your creative agency: the human approach
- Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...
